Tender Details | ||||||||
|
||||||||
Deadline * | ||||||||
|
||||||||
Client Address | ||||||||
|
||||||||
More Information | ||||||||
Know More |
Similar Tenders
- Ref No: 4141456
- Location: Lithunia
Procurement Of Services For The Preparation Of The Esg Strategy For The Preparation Of The Sustainability Report And The Creation Of The Plan For Its
- Deadline: 02 Apr 2029
- Ref No: 4210708
- Location: Germany
Order Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Medicinal Products With Th
- Deadline: 10 Aug 2026
- Ref No: 4608627
- Location: Canada
Concussion And Vestibular Physiotherapy Services
- Deadline: 18 Mar 2026
- Ref No: 4638957
- Location: Germany
Medicines With The Active Ingredient Tacrolimus Atc L04Ad02
- Deadline: 28 Feb 2026
- Ref No: 4641976
- Location: Germany
Medicines With The Active Ingredient Combination Oxycodone And Naloxone Atc N02Aa55
- Deadline: 28 Feb 2026
- Ref No: 5226107
- Location: Germany
Medicines With The Active Ingredient Combination Vilanterol Umeclidinium Bromide And Fluticasone Furoate Atc R03Al08
- Deadline: 31 Mar 2026
- Ref No: 5301821
- Location: Bulgaria
Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad
- Deadline: 27 May 2027
- Ref No: 5330444
- Location: France
Insurance For The Needs Of The Strasbourg Eurometropolis
- Deadline: 29 Oct 2024
- Ref No: 5396790
- Location: Germany
Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L
- Deadline: 27 Apr 2026
- Ref No: 5714435
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr
- Deadline: 30 Apr 2026
- Ref No: 5715804
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr
- Deadline: 30 Apr 2026